Drug intelligence / Profile preview

physioneal (Baxter International Inc.)

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Fixioneal (a regional brand name or common misspelling of Physioneal) is a peritoneal dialysis (PD) solution used for the treatment of patients with end-stage renal disease (ESRD). It is a bicarbonate/lactate-buffered solution containing glucose as an osmotic agent, along with essential electrolytes including sodium, calcium, magnesium, and chloride. Developed by Baxter, it is designed for use in Continuous Ambulatory Peritoneal Dialysis (CAPD) or Automated Peritoneal Dialysis (APD). The solution is formulated to be more biocompatible than traditional acidic, glucose-based PD solutions by maintaining a physiological pH (approximately 7.4) and reducing the formation of glucose degradation products (GDPs), which helps preserve the peritoneal membrane's function over long-term therapy. It is typically available in different buffer strengths, such as 35 mmol/L or 40 mmol/L, to tailor treatment to the patient's acid-base status.

Brand names
FixionealPhysioneal
Other names
Physioneal 35Physioneal35Physioneal-35Physioneal 40Physioneal40Physioneal-40

Beyond the preview

Go deeper on physioneal (Baxter International Inc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on physioneal (Baxter International Inc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call